DIANA STRIFFLER: Open Payments
NPI 1174861702 · NORWICH, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,972 in 101 payments from 18 companies in 2025. Trend: 2023 $744 · 2024 $1,654 · 2025 $1,972
Food & beverage: $1,972
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 24 | $469 |
| Novo Nordisk Inc | 22 | $426 |
| Xeris Pharmaceuticals, Inc. | 11 | $187 |
| Abbott Laboratories | 11 | $180 |
| Amgen Inc. | 8 | $159 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $123 |
| BETA BIONICS, INC. | 6 | $103 |
| Sequel Med Tech, LLC | 2 | $53 |
| CeQur Corporation | 1 | $52 |
| SANOFI-AVENTIS U.S. LLC | 2 | $49 |
Products named: Ozempic, JARDIANCE, MOUNJARO, FREESTYLE LIBRE 3, RECORLEV, TEPEZZA, iLet Bionic Pancreas, TWIIST.
Industry payments across CT — which companies pay providers there.
